1. Home
  2. PRHI vs LGVN Comparison

PRHI vs LGVN Comparison

Compare PRHI & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PRHI

Presurance Holdings Inc.

SELL

Current Price

$6.93

Market Cap

18.7M

Sector

Finance

ML Signal

SELL

Logo Longeveron Inc.

LGVN

Longeveron Inc.

HOLD

Current Price

$6.59

Market Cap

21.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRHI
LGVN
Founded
2009
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.7M
21.4M
IPO Year
2015
2021

Fundamental Metrics

Financial Performance
Metric
PRHI
LGVN
Price
$6.93
$6.59
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$3.00
AVG Volume (30 Days)
7.2K
505.2K
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
50.76
EPS
1.66
N/A
Revenue
$43,304,000.00
$709,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$10.81
P/E Ratio
$3.89
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$0.48
52 Week High
$7.95
$7.30

Technical Indicators

Market Signals
Indicator
PRHI
LGVN
Relative Strength Index (RSI) 67.98 89.30
Support Level $0.60 $0.61
Resistance Level N/A N/A
Average True Range (ATR) 1.02 0.28
MACD 0.07 0.62
Stochastic Oscillator 100.00 89.56

Price Performance

Historical Comparison
PRHI
LGVN

About PRHI Presurance Holdings Inc.

Presurance Holdings Inc is an insurance holding company that markets and services product offerings through specialty personal insurance lines of business. Through its personal insurance lines, it offers homeowners insurance and dwelling fire insurance products to individuals in several states. The specialty homeowners insurance product line is comprised of low-value dwelling insurance tailored for owners of lower valued homes, which it offers in Texas, Illinois and Indiana. Through commercial insurance lines, it offers coverage for both commercial property and commercial liability and also offered coverage for commercial automobiles and workers' compensation. Its revenues are derived from premiums earned from insurance operations.

About LGVN Longeveron Inc.

Longeveron Inc is a clinical stage biotechnology company developing regenerative medicines to address unmet medical needs. Its investigational product candidate is laromestrocel. Laromestrocel is a proprietary, scalable, allogeneic cellular therapy that has multiple potential modes of action that include pro-vascular, pro-regenerative, and anti-inflammatory mechanisms that collectively appear to promote tissue repair and healing. It is in clinical development of a single investigational product candidate, laromestrocel, for four potential indications: HLHS, Alzheimer's disease (AD), Pediatric Dilated Cardiomyopathy (pediatric DCM), and Aging-related Frailty. It operates in a single operating segment focused on developing regenerative medicines to address unmet medical needs.

Share on Social Networks: